Navigation Links
Genaera Corporation to Participate in Diabetes and Obesity Panel at RBC Capital Markets Healthcare Conference
Date:12/12/2007

PLYMOUTH MEETING, Pa., Dec. 12 /PRNewswire-FirstCall/ -- Genaera Corporation (Nasdaq: GENR) today announced that Jack Armstrong, President and Chief Executive Officer of Genaera, is scheduled to present at the 2007 RBC Capital Markets Healthcare Conference. The presentation is part of an RBC Capital Markets' panel discussion of diabetes and obesity, entitled, "The Pharmaceutical Sweet Spot: Diabetes & Obesity," and will take place in New York on Thursday, December 13 at 10:00 a.m. ET.

This panel presentation is being webcast at: http:/www.wsw.com/webcast/rbc84qpanel23

About Genaera

Genaera Corporation is focused on advancing the science and treatment of metabolic diseases. The Company has significant market opportunities with a first-in-class molecule, trodusquemine (MSI-1436), that has the potential to redefine the treatment paradigm for obesity and type 2 diabetes and is presently in a Phase 1 trial in obesity. In addition, Genaera has a value- driven, fully out-licensed partnership with MedImmune, Inc. for a second core program that is presently undergoing Phase 2 clinical testing in asthma. Genaera is committed to directing resources to its core program and the aggressive clinical development of its key assets to build stockholder value. For further information, please see our website at http://www.genaera.com.


'/>"/>
SOURCE Genaera Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Genaera Elects New Board Member and Announces Executive Appointments
2. Genaera to Present at Biotech 2007 and BIO InvestorForum
3. Genaera Corporation Announces Third Quarter Financial Results
4. Memry Corporation Announces Preliminary Fiscal Fourth Quarter and 2007 Revenue
5. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
6. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
7. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
8. BioElectronics Corporation Announces Singapore and Malaysia Sales
9. Avicena Signs Worldwide Exclusive Distribution Agreement with RITA Corporation for its Proprietary Dermaceutical Compounds
10. DURECT Corporation to Present at the NewsMakers in the Biotech Industry Investment Conference
11. Insulet Corporation to Present at the Thomas Weisel Partners Healthcare Conference on September 6, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2017)... ... 27, 2017 , ... The recent vote by the American Medication Association to ... hope to patients and hopefully sheds new light on the way health insurers, governments ... expert and founding partner of Texas Fertility Center . , “This designation ...
(Date:6/27/2017)... ... June 27, 2017 , ... Biodex Medical Systems, Inc. announces the release of ... This assistive aid lifts patients safely from a seated to a standing position without ... Mobility Assist is the latest in a line of Biodex products promoting safe patient ...
(Date:6/27/2017)... ... June 27, 2017 , ... ... its patented GX-1 yeast production and fermentation process. The efficiencies created by ... on micro-organism technologies, most notably the ethanol industry wherein individual production plants are ...
(Date:6/26/2017)... ... June 26, 2017 , ... ... the former Associate Director of Product Development R&D at Allergan and CMC expert ... at both start-up and established biopharma companies, has joined the firm as an ...
Breaking Biology Technology:
(Date:3/22/2017)... , March 21, 2017 ... Cloud used by retailers such as 1-800-Flowers and ... platform — Product Recommendations and Replenishment. Using Optimove,s machine ... more personalized product and replenishment recommendations to their ... also on predictions of customer intent drawn from ...
(Date:3/20/2017)... , March 20, 2017 At this year,s CeBIT ... -based biometrics manufacturer DERMALOG. The Chancellor came to the DERMALOG stand together ... is this year,s CeBIT partner country. At the largest German biometrics company ... use: fingerprint, face and iris recognition as well as DERMALOG´s multi-biometrics system.   ... ...
(Date:3/16/2017)... March 16, 2017 CeBIT 2017 - Against identity fraud with DERMALOG ... ... Used combined in one project, multi-biometric solutions provide a crucial contribution ... Used combined in one ... ...
Breaking Biology News(10 mins):